Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS

OBJECTIVE: To investigate the effects of natalizumab (NAT) treatment on intrathecally produced antiviral antibodies in MS. METHODS: We performed a longitudinal, observational study analyzing both serum and CSF samples collected before and during NAT treatment for antibodies against measles, rubella,...

Descripción completa

Detalles Bibliográficos
Autores principales: Largey, Fabienne, Jelcic, Ivan, Sospedra, Mireia, Heesen, Christoph, Martin, Roland, Jelcic, Ilijas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807967/
https://www.ncbi.nlm.nih.gov/pubmed/31554671
http://dx.doi.org/10.1212/NXI.0000000000000621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807967/
https://www.ncbi.nlm.nih.gov/pubmed/31554671
http://dx.doi.org/10.1212/NXI.0000000000000621

Ejemplares similares